Abstract

Introduction. Increasing of poorly soluble pharmaceutical substances bioavailability is one of important problems of pharmaceutical technology. Resveratrol is a plant origin polyphenol with a broad spectrum of biological effects. However, due to poor solubility and, as a result, low bioavailability, it is not promising for the development of oral drugs. Thus, today resveratrol is presented only as a biologically active substance that is component of biologically active food supplements.The objective of the research is selection of the optimal solubilizer to increase the solubility of resveratrol by determining the solubilization parameters.Materials and methods. The spectrophotometric characteristics of resveratrol were studied using three groups of solubilizers: poloxamers, polysorbates and cyclodextrins. Studies were carried out in 50 mM hydrochloric acid buffer(pH 1.2) and 50 mM phosphate buffer(pH 6.8). Spectrophotometric measurements were carried out on a spectrophotometer UV/VIS-3600 Shimadzu (Japan) in the wavelength range of 220–380 nm. The effect of solubilizers on the spectrophotometric characteristics of resveratrol was determined in buffer solutions containing the solubilizer and resveratrol in significantly less concentration of its own solubility in water. The used multiple excess of the solubilizer ensured the finding of all resveratrol in a solubilized form. During the determining parameters of solubilization, buffer solutions containing from 2 to 10 mM solubilizers were added to the obviously excess of resveratrol. The indicated amount of resveratrol ensured the presence of its precipitate in all experimentsto determine the completeness of solubilization of the studied polyphenol.Results. Based on the obtained spectrophotometric characteristics of solubilizers solutions with resveratrol, the most effective for the further development of solid dosage forms for oral administration are poloxamer 407, polysorbate 80 and modified methyl-beta-cyclodextrin, which ensure complete dissolution of resveratrol when its content in the composition with a solubilizer is about 10 %.Conclusion. Based on the data obtained on the spectrophotometric characteristics of resveratrol using solubilizers, it can be argued that it is possible to create drugs with improved solubility of the studied polyphenol. On the basis of its compositions with poloxamer 407, polysorbate 80 and modified methyl-beta-cyclodextrin, with the selection of appropriate excipients, solid dosage forms for oral intake can be developed.

Highlights

  • Increasing of poorly soluble pharmaceutical substances bioavailability is one of important problems of pharmaceutical technology

  • The objective of the research is selection of the optimal solubilizer to increase the solubility of resveratrol by de­ termining the solubilization parameters

  • The effect of solubilizers on the spectrophotometric characteristics of resveratrol was determined in buffer solutions containing the solubilizer and resveratrol in significantly less concentration of its own solubility in water

Read more

Summary

Обоснование оптимального состава композиций ресвератрола с солюбилизаторами

Цель исследования – выбор оптимального солюбилизатора для увеличения растворимости ресвератрола посредством определения параметров солюбилизации. Были изучены спектрофотометрические характеристики ресвератрола при использовании 3 групп солюбилизаторов: полоксамеров, полисорбатов и циклодекстринов. Влияние солюбилизаторов на спектрофотометрические характеристики ресвератрола изучали в буферных растворах, содержащих солюбилизатор и ресвератрол в концентрации, существенно меньшей, чем его собственная растворимость в воде. При определении параметров солюбилизации к заведомому избытку ресвератрола добавляли буферные растворы, содержащие от 2 до 10 мМ солюбилизаторов. Такое количество ресвератрола обеспечивало наличие его осадка во всех экспериментах для определения полноты солюбилизации исследуемого полифенола. Исходя из полученных спектрофотометрических характеристик растворов солюбилизаторов с ресвератролом наиболее привлекательными для дальнейшей разработки твердых лекарственных форм для перорального приема выступают полоксамер 407, полисорбат 80 и модифицированный метил‐бета‐циклодекстрин, обеспечивающие полное растворение исследуемого полифенола при его содержании в композиции с солюбилизатором около 10 %.

Introduction
Without solubilizer
Солюбилизатор Solubilizer
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.